Beauty and the beast: host microRNA-155 versus SARS-CoV-2.

Papadopoulos, K I; Papadopoulou, A; Aw, T C

Papadopoulos, K I; Papadopoulou, A; Aw, T C.

Papadopoulos KI; THAI StemLife, 566/3 Soi Ramkhamhaeng 39 (Thepleela 1), Prachaouthit Rd., Wangthonglang, Bangkok, 10310, Thailand. kostas@thaistemlife.co.th.
Papadopoulou A; Occupational and Environmental Health Services, Feelgood Lund, Ideon Science Park, Scheelevägen 17, 223 63, Lund, Sweden.
Aw TC; Department of Laboratory Medicine, Changi General Hospital, 2 Simei Street 3, Singapore, 529889, Singapore.

Hum Cell ; 36(3): 908-922, 2023 May.

Article en En | MEDLINE | ID: mdl-36847920

Asunto(s)

COVID-19; MicroARNs; Humanos; SARS-CoV-2; COVID-19/genética; Peptidil-Dipeptidasa A; Angiotensina II; Antivirales; MicroARNs/genética

Palabras clave

Angiotensin-converting enzyme 1; Angiotensin-converting enzyme 2; Erythropoietin; MicroRNA-155; Renin-angiotensin aldosterone system; Severe acute respiratory coronavirus 2

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: MicroARNs / COVID-19 Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: MicroARNs / COVID-19 Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article